|Bid||65.11 x 900|
|Ask||65.09 x 1300|
|Day's range||64.05 - 65.17|
|52-week range||60.89 - 85.97|
|Beta (5Y monthly)||0.58|
|PE ratio (TTM)||N/A|
|Earnings date||22 Oct 2020 - 26 Oct 2020|
|Forward dividend & yield||2.72 (4.18%)|
|Ex-dividend date||14 Sep 2020|
|1y target est||78.92|
Clinical trial results, coronavirus vaccine progress, and a buyout were the major factors that turned these biotech stocks into big gainers last week. Shares of this biotech took flight last week after the company told investors the FDA approved an investigational new drug (IND) application for the company's oral coronavirus vaccine candidate.
Generous dividends and long-term staying power make these two companies appealing to buy at a bargain.
Williams-Sonoma, Tanger Factory Outlet, Gilead Sciences, Immunomedics and Jounce Therapeutics highlighted as Zacks Bull and Bear of the Day